eye5
Основные мероприятия ассоциации офтальмологов
Beaver
профессор
santen
camopht
medlab
Флаги
oftalmolog_club
glaucoma_net_ru
Mobile
www.worldglaucoma.org
конгресс 2018
varthamana2
Торика
Первая пятница декабря
YouTube
nidek
Конгресс
Ассоциации
bannerparasol
ВК
icgs2018
appstore
Шахматы
askin_heid
АйНьюс.РФ
Конгресс 2014
facebook
icglaucoma.org
Главная / Новости

Новости


3 4 5 6 7 8 9 10 11 12


26 января 2017 - Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP
Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma medications achieve this almost exclusively through reduction of intraocular pressure (IOP). Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure is the only known modifiable risk factor for patients with glaucoma, so improvements in patient outcomes rely on tight IOP control and patient adherence to therapy. In this educational activity, leading clinicians review established and new therapeutic agents for patients with glaucoma, including the recent clinical evidence for their safety and efficacy. In addition, discussion will comprise the recent evidence concerning the effects of low perfusion pressure on glaucoma development and progression.

25 января 2017 - Who are the ideal patients?
А что Вы думаете по этому поводу?

22 января 2017 - Top Eye Care Stories of 2016
Подробнее внутри!

20 января 2017 - Abstract submission deadline: 10 days left!
The Scientific Committee invites you to participate actively in this congress which will be an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the program as oral or poster presentations.

18 января 2017 - Early to Advanced AMD: Defining the Importance of Prompt Diagnosis and Treatment
Management of the geographic atrophy seen in late-stage dry age-related macular degeneration (AMD) poses several challenges. Scientific understanding of geographic atrophy continues to develop, and recent changes have been made to how this condition is classified, which underscores the importance of accurately monitoring progression. Although no treatment has been approved to manage late-stage dry AMD, complement inhibition, visual cycle modulation, neuroprotection, and stem cell therapy have had encouraging results in clinical trials

15 января 2017 - Understanding Corneal Stem Cells Through Stripes
Fusing the embryos of mice, where one contains a marker of its lineage, is a well-established technique in developmental biology research. The stripy corneas were still a surprise, though…

09 января 2017 - Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
Purpose: To systematically review anatomical and functional outcomes subsequent to switching from bevacizumab/ranibizumab to aflibercept monotherapy in patients with treatment-resistant neovascular age-related macular degeneration (nAMD).

04 января 2017 - Deadline for WGC-2017 abstract & clinical case submission: January 30!
The Scientific Committee invites you to participate actively in this congress which will be an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the program as oral or poster presentations

30 декабря 2016 - Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening
Скоро Новый год, а мы все о глаукоме)

25 декабря 2016 - В новом году разместим на сайте Новости глаукомы
Полный текст будет размещен в 2017 году

23 декабря 2016 - GenSight reports visual acuity gains in phase 1/2 study of GS010 for Leber’s hereditary optic neuropathy
GenSight Biologics reported sustained visual acuity improvement in patients with Leber’s hereditary optic neuropathy who were treated with GS010 in a phase 1/2 clinical trial

22 декабря 2016 - The International Committee of Medical Journal Editors has updated the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
The International Committee of Medical Journal Editors has updated the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. The updated Recommendations may be found and downloaded at www.icmje.org. To assist in identifying where changes have been made, an annotated copy of the Recommendations is available at our website under “News & Editorials.”

20 декабря 2016 - ICO’s Global Call for Action to Eliminate Surgical Eye Errors
Patient safety is a high priority for the World Health Organization and all of us, and we ask that you support, share, and promote the ICO’s Global Call for Action to Eliminate Surgical Eye Errors

19 декабря 2016 - Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Real-World Insights on Optimising Visual Acuity While Reducing Treatment Burden
Anat Loewenstein, MD: Hello, my name is Anat Loewenstein from the Tel Aviv Medical Centre, and the Tel Aviv University in Tel Aviv, Israel. Welcome to this PeerVoice activity on neovascular age-related macular degeneration

16 декабря 2016 - Фото с Конгресса Российского глаукомного общества
Посмотреть можно на странице в Фейсбуке https://www.facebook.com/GlaucomaNews

13 декабря 2016 - Ophthalmology Conference will emphasis on “Exploring the novel research and trends in clinical and surgical ophthalmology "
Информация на http://ophthalmology.conferenceseries.com/asiapacific/

08 декабря 2016 - Advice from one who’s been there and done that
At a Glance Taking an idea and turning it into reality can be an incredibly long and arduous journey There are a number of pitfalls you need to avoid – IP, finance and competitors John Marshall has invented and pioneered many technologies in eyecare and beyond – he’s far more than the inventor of the excimer laser Here, he shares his insights and his stories of innovation

06 декабря 2016 - Коллеги, результаты конкурса о биомикроскопии опубликованы!
Пора познакомиться с результатами!

30 ноября 2016 - Да, одни полные сутки до начала!
Сопротивление - бесполезно!


3 4 5 6 7 8 9 10 11 12
Голосование
Что "заставляет" Вас заниматься научными исследованиями?